Immugenia Inc.
PrivateLast Round
Grant
Oct 15, 2024
Company Overview
Immugenia Inc. is a biotechnology company that develops immuno-oncology therapies by engineering hematopoietic stem cells to treat cancer and prevent relapses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immugenia Inc. Comparables
Compare Immugenia Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ensoma | 76% | |
| EXUMA Biotech | 73% | |
| Chromatin Bioscience | 73% | |
Immugenia Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 15, 2024 | ||||
| Pre Seed | Oct 6, 2022 |
Immugenia Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brain Canada Foundation | Grant |
| Consortium Québécois sur la découverte du médicament | Grant |
| Accélérateur de création d'entreprises technologiques | Pre Seed |
| adMare BioInnovations | Pre Seed |
| Sherbrooke Innopole | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 15, 2024
$3M grant received from Brain Canada Foundation and others.
- Oct 6, 2022
Secured funding from adMare BioInnovations, Accélérateur de création d'entreprises technologiques, and Sherbrooke Innopole.
Immugenia Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Immugenia Inc.'s valuation, stock price, and market status.